New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome
Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says
High Radiation Dose Effective Ten Years After Treatment
New Risk Stratification Method For Prostate Cancer Described
Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan
Survival After Liver Transplant Called Excellent In Study
Tumor Size Predicts Survival In Early-Stage Lung Cancer
B-27 Finds Improved CR For Taxotere Prior To Surgery
Studies Link Age-Dependent Outcome To Immune Cells
Clinical Trials Approved By NCI
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Foundations acquire a critical new role as federal funding for cancer research falters
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Our challenge: To find zen in chaos
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”